Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.18 USD | -12.45% | -8.21% | -82.48% |
05-14 | Transcript : Vivos Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Vivos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-82.48% | 7.43M | |
+73.63% | 12.43B | |
-18.62% | 8.09B | |
-0.90% | 6.12B | |
+14.66% | 5.59B | |
-14.69% | 5.47B | |
+39.93% | 5.23B | |
-16.51% | 4.1B | |
-27.62% | 2.65B | |
+1.36% | 1.99B |
- Stock Market
- Equities
- VVOS Stock
- News Vivos Therapeutics, Inc.
- Ascendiant Capital Starts Vivos Therapeutics at Buy With $2.50 Price Target